| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.46 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |